The future of incretin-based therapy: novel avenues-novel targets
Author:
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2011.01457.x/fullpdf
Reference72 articles.
1. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes.;Drucker;Lancet,2006
2. Alpha-cell function in health and disease: influence of GLP-1.;Dunning;Diabetologia,2005
3. The role of GLP-1 in the life and death of pancreatic beta-cells.;Perfetti;Horm Metab Res,2004
4. Antidiabetic effect of glucagon-like peptide-1 (7-36) amide in normal subjects and patients with diabetes mellitus.;Gutniak;N Engl J Med,1992
5. Islet G-protein-coupled receptors as potential targets for treatment of type 2 diabetes.;Ahrén;Nat Rev Drug Discov,2009
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Discovery of Novel 5,6-Dihydro-1,2,4-triazine Derivatives as Efficacious Glucagon-Like Peptide-1 Receptor Agonists;Journal of Medicinal Chemistry;2023-06-07
2. Role of Glucagon and Its Receptor in the Pathogenesis of Diabetes;Frontiers in Endocrinology;2022-06-16
3. The Relevance of Metabotrophic Factors in Pathobiology and Therapy of Obesity and Related Diseases;Cellular and Biochemical Mechanisms of Obesity;2021
4. The role of incretin-based therapies in the management of type 2 diabetes mellitus: perspectives on the past, present and future;Diabetes mellitus;2020-01-17
5. Molecular mechanism of an antagonistic antibody against glucose-dependent insulinotropic polypeptide receptor;mAbs;2020-01-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3